Log In
Print this Print this

Theraloc, nimotuzumab (Vecthix, BiomAb-EGFR) (DE-766, OSAG101)

Also known as: formerly TheraCIM hR3

  Manage Alerts
Collapse Summary General Information
Company InnoKeys Pte. Ltd.
DescriptionHumanized IgG1 mAb against EGFR
Molecular Target Epidermal growth factor receptor (EGFR)
Mechanism of ActionBinds epidermal growth factor (EGF) receptor; Antibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today